An intron 1 polymorphism in the cholecystokinin-A receptor gene associated with schizophrenia in males

Acta Psychiatrica Scandinavica

Volumn 120, Issue 4, 2009, Pages 281-287

  Koefoed, P ^a   Hansen, T V O ^a   Woldbye, D P D ^a   Werge, T ^b   Mors, O ^c   Hansen, T ^b   Jakobsen, K D ^b,d   Nordentoft, M ^a   Wang, A ^e   Bolwig, T G ^a   Rehfeld, J F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Sct Hans Hospital   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e AMAGER HOSPITAL   (Denmark)

Author keywords

Case control study; Cholecystokinin A receptor gene; RNA splicing; Schizophrenia; Sex differences

Indexed keywords

CHOLECYSTOKININ A RECEPTOR;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR GENE; RISK FACTOR; RNA SPLICING; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 4; DENMARK; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE EXPRESSION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTRONS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, CHOLECYSTOKININ A; RNA SPLICE SITES; RNA, MESSENGER; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 70349155811     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01400.x     Document Type: Article

References (40)

1. Sullivan PF. The genetics of schizophrenia. PloS Med 2005 2 : e212.
2. Nemeroff CB, Bissette G. Neuropeptides, dopamine, and schizophrenia. Ann NY Acad Sci 1988 537 : 273 291.
3. Fonti MD, Lappin JM, Myrray RM. Risk factors for schizophrenia - all roads lead to dopamine. Eur Neuropsychopharmacol 2007 17 (Suppl 2 S101 S107.
4. Talkowski ME, Kirov G, Bamne M et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum Mol Genet 2008 17 : 747 758.
5. Hökfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M, Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurons. Nature 1980 285 : 476.
6. Skirboll LR, Grace AA, Hommer DW et al. Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons. Neuroscience 1981 6 : 2111 2114.
7. Li XM, Hedlund PB, Fuxe K. Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections. Eur J Neurosci 1995 7 : 962 971.
8. Crawley JN. Cholecystokinin-dopamine interactions. TiPS 1991 12 : 232 236.
9. Asherson P, Mant R, Williams N et al. A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mol Psychiatry 1998 3 : 310 320. (Pubitemid 28379914)
10. Christoforou A, Le Hallard S, Thomson PA et al. Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia. Mol Psychiatry 2007 12 : 1011 1025.
11. Tachikawa H, Harada S, Kawanishi Y, Okubo T, Shiraishi H. Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 2000 96 : 141 145. (Pubitemid 30180851)
12. Toirac I, Sanjuán J, Aguilar EJ et al. Association between CCK-AR gene and schizophrenia with auditory hallucinations. Psychiatr Genet 2007 17 : 47 53.
13. Wei J, Hemmings GP. The CCK-A receptor gene possibly associated with auditory hallucinations in schizophrenia. Eur Psychiatry 1999 14 : 67 70.
14. Zhang XY, Zhou DF, Zhang PY, Wei J. The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia. Mol Psychiatry 2000 5 : 239 240.
15. Sanjuan J, Toirac I, González JC et al. A possible association between the CCK-AR gene and persistent auditory hallucinations in schizophrenia. Eur Psychiatry 2004 19 : 349 353.
16. Minato T, Tochigi M, Kato N, Sasaki T. Association study between the cholecystokinin A receptor gene and schizophrenia in the Japanese population. Psychiatr Genet 2007 17 : 117 119. (Pubitemid 46586684)
17. Thorup A, Petersen L, Jeppesen P et al. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. J Nerv Ment Dis 2007 195 : 396 405.
18. WHO. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva : World Health Organization, 1993.
19. Jakobsen KD, Frederiksen JN, Hansen T et al. Reliability of clinical ICD-10 schizophrenia diagnoses. Nordic J Psychiatry 2005 59 : 209 212.
20. Jakobsen KD, Frederiksen JN, Parnas J, Werge T. Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses. Psychopathology 2006 39 : 269 276.
21. Wing JK, Sartorius N, Üstün TB, Editors. Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN. Geneva : World Health Organization, 1998.
22. Kessing LV, Jørgensen OS. Apolipoprotein E-η4 frequency in affective disorder. Biol Psychiatry 1999 45 : 430 434.
23. Mellerup E, Bennike B, Bolwig T et al. Platelet serotonin transporters and the transporter gene in control subjects, unipolar patients and bipolar patients. Acta Psychiatr Scand 2001 103 : 229 233.
24. 2A receptors in normal volunteers: normative data and relationship to physiological and demographic variables. NeuroImage 2004 21 : 1105 1113.
25. Church DM, Stotler CJ, Rutter JL, Murrell JR, Trofatter JA, Buckler AJ. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat Genet 1994 6 : 98 105.
26. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand 2000 101 : 3 38.
27. Thorup A, Waltoft BL, Pedersen CB, Mortensen PB, Nordentoft M. Young males have a higher risk of developing schizophrenia: a Danish register study. Psychol Med 2007 37 : 479 484.
28. Riecher-Rossler A, Hafner H, Stumbaum M, Maurer K, Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994 20 : 203 214.
29. Ko YH, Joe SH, Cho W et al. Estrogen, cognitive function and negative symptoms in female schizophrenia. Neuropsychobiology 2006 53 : 169 175.
30. Ko YH, Jung AW, Joe SH et al. Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia. Psychoneuroendocrinology 2007 32 : 385 391.
31. Hallonquist JD, Seeman MV, Lang M, Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993 33 : 207 209.
32. Halari R, Kumari V, Mehrotra R, Wheeler M, Hines M, Sharma T. The relationship of sex hormones and cortisol with cognitive functioning in schizophrenia. J Psychopharmacology 2004 18 : 366 374.
33. Hilke S, Hökfelt T, Darwish M, Theodorsson E. Cholecystokinin levels in the rat brain during the estrous cycle. Brain Res 2007 1144 : 70 73.
34. Micevych P, Eckersell CB, Holland KL, Smith A. Induction of CCK mRNA levels in the limbic-hypothalamic circuit: time course and site-specific effects of estrogen. J Neurobiol 1996 30 : 465 479.
35. Micevych P, Ulibarri C. Development of the limbic-hypothalamic cholecystokinin circuit: a model of sexual differentiation. Dev Neurosci 1992 14 : 11 34.
36. Popper P, Priest CA, Micevych P. Regulation of cholecystokinin receptors in the ventromedial nucleus of the hypothalamus: sex steroid hormone effects. Brain Res 1996 712 : 335 339.
37. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic arcthitecture of quantitative traits in humans. Nat Genet 2006 38 : 218 222.
38. Rinn JL, Snyder M. Sexual dimorphism in mammalian gene expression. Trends Genet 2005 21 : 298 305.
39. Pickard BS, Thomson PA, Christoforou A et al. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 2007 17 : 129 133.
40. Shifman S, Johannesson M, Bronstein M et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genet 2008 4 : e28 Epub ahead of print X, Wang X, Hossain S et al. Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia. Hum Mol Genet 2006 15 : 3329 3342.